ADHD and Perimenopause: What Happens to Your Dopamine
I'd spent years finding ways to work with my ADHD. Then perimenopause arrived, and almost overnight it felt as though none of them worked anymore.
My anxiety became overwhelming, my emotional regulation disappeared, imposter syndrome took over, social situations became exhausting, and coping with everyday life suddenly felt impossible. It got to the point where I wanted to leave my career as a nurse, and it took me to one of the darkest points in my life.
I'd only recently been diagnosed with ADHD, and just as I was beginning to understand how my brain worked, everything changed again.
It wasn't until I started reading the research that I realised one of the biggest reasons was dopamine, and the enormous role oestrogen plays in supporting it.
Understanding what was happening changed everything. It helped me stop blaming myself and finally make sense of why the strategies that had worked for years had stopped working.
What Does Dopamine Actually Do?
One of the biggest reasons ADHD symptoms often get worse during perimenopause comes down to dopamine.
Dopamine is one of the brain's most important chemical messengers. It plays a key role in attention, motivation, emotional regulation, working memory, planning and decision making. It helps you get started on tasks, stay focused, and experience enough reward to keep going.
One of the reasons ADHD can feel so frustrating is that the brain responds much more strongly to interest, urgency and novelty than it does to importance. A task can matter enormously, but if it doesn't feel interesting or urgent in that moment, getting started can feel almost impossible.
ADHD is often described as a dopamine deficiency, as though the brain doesn't produce enough dopamine. The evidence suggests the picture is more complicated than that (MacDonald et al., 2024).
For most people with ADHD, the problem isn't producing dopamine. It's regulating it.
Think of it like having a really unreliable WiFi signal. The internet hasn't disappeared, but the connection keeps dropping in and out. That's a bit like dopamine in ADHD. The brain can produce it, but it struggles to keep it available where and when it's needed. That inconsistency is why focus, motivation and emotional regulation can fluctuate so much.
This also helps explain why stimulant medication works. Rather than creating dopamine that wasn't there before, medications such as methylphenidate and amphetamines help dopamine stay available for longer, giving the brain more opportunity to use it (MacDonald et al., 2024).
Why Oestrogen Matters So Much
This is where perimenopause changes everything.
Oestrogen doesn't produce dopamine itself, but it supports almost every part of the dopamine system. It helps the brain produce dopamine, helps it remain available for longer, and helps brain cells respond to it more effectively (Georgiou, 2024; Keenan et al., 2001).
In other words, oestrogen has been supporting your dopamine system for years, without you ever noticing it was happening.
For women with ADHD, that's particularly important. The underlying ADHD has always been there, but oestrogen has often been compensating for some of the difficulties without anyone realising it. It wasn't fixing ADHD, but it was helping the brain work around it.
Why ADHD Symptoms Often Get Worse During Perimenopause
During perimenopause, oestrogen doesn't decline in a straight line. Instead, it fluctuates, sometimes dramatically, over months or even years before eventually settling after menopause (Kooij et al., 2025).
As those hormone levels fluctuate, the support your dopamine system has been relying on fluctuates too. This is why so many women describe feeling as though everything changed almost overnight.
Tasks that once felt manageable become overwhelming. Focus becomes harder. Motivation disappears. Emotional regulation becomes more difficult. Anxiety increases. Sleep deteriorates. The routines and strategies you've relied on for years can stop working almost overnight.
Many women describe this as the point where everything fell apart, even though nothing else in their lives had changed.
They hadn't become lazy.
They hadn't lost their work ethic.
Their brain chemistry had changed.
For many women, this is also the point where ADHD is recognised for the first time. Looking back, the signs were often there all along, but once oestrogen begins to fluctuate, the coping strategies that had been holding everything together can stop working almost overnight.
Research now supports what many women have been describing for years. A large population based study found that women with ADHD experience more severe perimenopausal symptoms, and often experience them earlier, than women without ADHD (Jakobsdóttir Smári et al., 2025).
What Actually Helps
Once you understand that this is a hormone and dopamine problem rather than a personal failing, the practical picture becomes much clearer.
HRT that restores oestrogen doesn't just ease hot flushes and night sweats. Because oestrogen supports dopamine production, availability and receptor sensitivity, restoring it can have a direct effect on focus, motivation and emotional regulation too, which is why so many women with ADHD describe HRT as transformative rather than mildly helpful (Sharma et al., 2023).
ADHD medication may also need reviewing during this time. That isn't a sign the medication has stopped working, or that you've built up a tolerance. It's a sign the hormonal environment your medication is working within has changed, and the dose that served you for years may now need revisiting.
Working with your dopamine system, rather than fighting it, still matters here too. Interest, urgency and novelty will get you further than effort alone, especially while your hormonal support is in flux. That isn't a failure of willpower. It's how this particular brain, in this particular season, actually works.
You Are Not Failing
If you're in perimenopause and everything that used to work has stopped working, please hear this: it isn't you. Your brain chemistry has changed, and it changed for reasons that had nothing to do with effort, discipline, or how much you wanted it to work.
Understanding what's happening at a hormonal level doesn't fix it overnight, but it does mean you can stop blaming yourself and start asking better questions, about your hormones, your medication, and what support actually looks like for your brain right now.
What would change for you if you stopped treating this as a personal failing, and started treating it as a brain that needs different support than it used to?
The research referenced in this article is listed below if you'd like to explore the evidence in more detail.
References
Brinton, R.D., Yao, J., Yin, F., Mack, W.J. and Cadenas, E. (2015) 'Perimenopause as a neurological transition state', Nature Reviews Endocrinology, 11(7), pp. 393–405. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9934205/
Georgiou, P. (2024) 'The impact of estradiol on serotonin, glutamate, and dopamine systems', Frontiers in Neuroscience, 18, article 1348551. Available at: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1348551/full
Jakobsdóttir Smári, U., Valdimarsdottir, U.A., Wynchank, D., de Jong, M., Aspelund, T., Hauksdottir, A., Thordardottir, E.B., Tomasson, G., Jakobsdottir, J., Lu, D., Nevriana, A., Larsson, H., Kooij, S. and Zoega, H. (2025) 'Perimenopausal symptoms in women with and without ADHD: A population based cohort study', European Psychiatry. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12538516/
Keenan, P.A., Ezzat, W.H., Ginsburg, K. and Moore, G.J. (2001) 'Prefrontal cortex as the site of estrogen's effect on cognition', Psychoneuroendocrinology, 26(6), pp. 577–590. Available at: https://pubmed.ncbi.nlm.nih.gov/11403979/
Kooij, J.J.S. et al. (2025) 'Research advances and future directions in female ADHD: The lifelong interplay of hormonal fluctuations with mood, cognition, and disease', Frontiers in Global Women's Health, 6, article 1613628. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12277363/
MacDonald, H.J., Kleppe, R., Szigetvari, P.D. and Haavik, J. (2024) 'The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models', Frontiers in Psychiatry, 15, article 1492126. Available at: https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1492126/full
Sharma, A., Goel, A., Dhayalan, J., Kamali Zare, V., Hanson, L. and Yalamanchi, S. (2023) 'The effect of hormone replacement therapy on cognition and mood', Clinical Endocrinology, 98(3), pp. 285–295. Available at: https://onlinelibrary.wiley.com/doi/10.1111/cen.14856
